Benazepril Hcl
Brand names: Benazepril Hcl
At a glance
- Medicare prescriptions, 2024
- 1,556,350
- Medicare drug cost
- $16.0M
- Average cost per prescription
- $10.28
- Clinicians who prescribed it
- 60,122
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Amlodipine and benazepril hydrochloride capsules are a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin-converting enzyme (ACE) inhibitor.
From the FDA-approved prescribing information (label dated October 2026). Full labels on DailyMed (opens in a new tab)
Boxed warning
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride capsules as soon as possible. Drugs that act directly on the renin-angiotensin system (RAS) can cause injury and death to the developing fetus. WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride capsules as soon as possible. Drugs that act directly on the renin-angiotensin system (RAS) can cause injury and death to the developing fetus.
The FDA’s strongest warning on a label. It doesn’t mean the drug is unsafe for most people; talk to your doctor or pharmacist before stopping or changing any medicine.
Who prescribes it
- Family Medicine 40.3%
- Internal Medicine 30.1%
- Nurse Practitioners 12.2%
- Physician Assistants 5.1%
- Cardiology 4.7%
- Interventional Cardiology 1.6%
- General Practice 1.4%
- Geriatric Medicine 1.2%
- Nephrology (Kidney) 1.0%
- Endocrinology & Diabetes 0.3%
- Hospitalist 0.2%
- Pediatrics 0.2%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 21% from 2019 to 2024.
Biggest change by state since 2019
- Massachusetts −3%
- Connecticut −11%
- Maine −11%
- Utah −11%
- New Hampshire −12%
- Mississippi (smallest change) −33%
- South Carolina (smallest change) −28%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 3 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Ax Pharmaceutical Corp
| Strength | Looks like | Imprint |
|---|---|---|
| 49.5 g | white powder | |
Bluebay Shandong Co.,ltd
| Strength | Looks like | Imprint |
|---|---|---|
| 1 g | white powder | |
Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 2.5 mg / 10 mg benazepril hydrochloride | white capsule, 14 mm | 920 |
| 5 mg / 10 mg benazepril hydrochloride | brown capsule, 14 mm | 921 |
| 5 mg / 20 mg benazepril hydrochloride | pink capsule, 16 mm | 922 |
| 5 mg / 40 mg benazepril hydrochloride | blue capsule, 18 mm | 923 |
| 10 mg / 20 mg benazepril hydrochloride | purple capsule, 18 mm | 924 |
| 10 mg / 40 mg benazepril hydrochloride | blue capsule, 19 mm | 925 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Jul 2025 · Lupin Pharmaceuticals Inc. · Class II
Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.